3T Biosciences
TCR Target ID And Therapeutic Discovery
South San Francisco, United States · Founded 2017 · $40.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- 3tbiosciences.com
- Total Funding
- $40.0M
- Last Round
- $40.0M Series AAug 2022
- Rounds
- 2
About
Immunotherapy company developing next-generation TCR-based therapeutics for cancer treatment.
Summary
3T Biosciences is a Biotech company based in South San Francisco, United States, founded in 2017. It has raised $40.0M in total across 2 rounds, most recently a $40.0M Series A round in Aug 2022. Investors include Westlake Village BioPartners and Lightspeed VP.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2022
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/3t-biosciences"><img src="https://indexed.vc/api/badge/company/3t-biosciences" alt="3T Biosciences on Indexed.vc" width="260" height="76" /></a>